Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex-Reference-Cited by-同舟云学术

Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex

Published:2015-08 Issue: Volume:95 Page:388-394
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Kiritoshi Takaki,Neugebauer Volker^ORCID

Funder

National Institute of Neurological Disorders and Stroke (NIH/NINDS)

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference44 articles.

1. Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model;Adedoyin;Mol. Pain,2010

2. Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice;Ago;Neuropharmacology,2013

3. Neural mechanisms of pain and alcohol dependence;Apkarian;Pharmacol. Biochem. Behav.,2013

4. Chronic pain patients are impaired on an emotional decision-making task;Apkarian;Pain,2004

5. Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo;Bond;J. Pharmacol. Exp. Ther.,2000

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Presynaptic glutamate receptors in nociception;Pharmacology & Therapeutics;2023-11

2. Differences in the neural basis and transcriptomic patterns in acute and persistent pain-related anxiety-like behaviors;Frontiers in Molecular Neuroscience;2023-05-26

3. Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors;Cells;2022-08-21

4. Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease;Pharmacological Reviews;2022-06-16

5. Optogenetic manipulations of CeA-CRF neurons modulate pain- and anxiety-like behaviors in neuropathic pain and control rats;Neuropharmacology;2022-06